Targeted therapies for sarcomas: new roles for the pathologist

Area of Science:

• Oncology
• Pathology
• Genetics

Background:

• Sarcomas are diverse cancers originating from connective tissues.
• Traditional pathology focuses on diagnosis and grading for treatment.
• Emerging targeted therapies necessitate understanding molecular alterations.

Purpose of the Study:

• To review the evolving role of pathologists in sarcoma care.
• To highlight the importance of molecular characterization in sarcomas.
• To discuss targeted therapies and their impact on patient management.

Main Methods:

• Literature review of sarcoma pathogenetic mechanisms.
• Enumeration of molecular derangements in soft tissue sarcoma.
• Discussion of targeted agents in clinical use or investigation.

Main Results:

• Pathologists' roles extend beyond diagnosis to molecular profiling.
• Awareness of genetic features is key for multidisciplinary sarcoma care.
• Specific sarcomas like DFSP and GIST exemplify the impact of molecular insights.

Conclusions:

• Molecular characterization by pathologists significantly influences sarcoma treatment.
• Targeted therapies offer new avenues for managing various sarcomas.
• An integrated approach combining pathology and molecular genetics optimizes patient outcomes.